Cargando…

SensiScreen(®) KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations

Activating mutations in codon 12 and codon 13 of the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene are implicated in the development of several human cancer types and influence their clinical evaluation, treatment and prognosis. Numerous different methods for KRAS genotyping are currently a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riva, Alice, BØrgesen, Michael, Guldmann-Christensen, Mariann, Hauge Kyneb, Majbritt, Voogd, Kirsten, Andersen, Christina, Epistolio, Samantha, Merlo, Elisabetta, Yding Wolff, Tine, Hamilton-Dutoit, Stephen, Lorenzen, Jan, Christensen, Ulf Bech, Frattini, Milo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479524/ https://www.ncbi.nlm.nih.gov/pubmed/28636636 http://dx.doi.org/10.1371/journal.pone.0178027

Ejemplares similares

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen(®) FFPE BRAF qPCR assay
por: Sørensen, Anna Lahn, et al.
Publicado: (2023)

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies
por: Jensen, Steffen Grann, et al.
Publicado: (2021)

Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
por: Guo, Tianan, et al.
Publicado: (2021)

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
por: Guedes, Joana G, et al.
Publicado: (2013)

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
por: Ramteke, Manoj P., et al.
Publicado: (2016)

MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis
por: Lu, Daniel, et al.
Publicado: (2022)

Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells
por: Wong, Hung Lai, et al.
Publicado: (2018)

Photowalk 2015 - Cristina Sensi
por: Sensi, Cristina
Publicado: (2015)

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy
por: Cefalì, Marco, et al.
Publicado: (2022)

Impact of Specific KRAS Mutation in Exon 2 on Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients
por: Roszkowski, Krzysztof, et al.
Publicado: (2014)

A case of low-grade intestinal-type mucinous neoplasm of the fallopian tube with KRAS exon 2 mutation
por: Nagahama, Kiyotaka, et al.
Publicado: (2023)

Analysis of KRAS Mutations of Exon 2 Codons 12 and 13 by SNaPshot Analysis in Comparison to Common DNA Sequencing
por: Zinsky, Rica, et al.
Publicado: (2010)

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
por: Hsu, Hung‐Chih, et al.
Publicado: (2019)

The Absence of Mutations in the Exon 2 KRAS Gene in Several Ethnic Groups in North Sumatra May Not the Main Factor for Lung Cancer
por: Soeroso, Noni Novisari, et al.
Publicado: (2021)

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines
por: Weißbach, Susann, et al.
Publicado: (2020)

Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma
por: De Falco, Elena, et al.
Publicado: (2021)

Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
por: Adachi, Yuta, et al.
Publicado: (2021)

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
por: Elez, Elena, et al.
Publicado: (2019)

Joint effects of polycyclic aromatic hydrocarbons, smoking, and XPC polymorphisms on damage in exon 2 of KRAS gene among young coke oven workers
por: Chen, Siqin, et al.
Publicado: (2022)

Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules
por: Frattini, Milo, et al.
Publicado: (2021)

Detection of internal exon deletion with exon Del
por: Guo, Yan, et al.
Publicado: (2014)

JuncDB: an exon–exon junction database
por: Chorev, Michal, et al.
Publicado: (2016)

Second-line panitumumab as a triweekly dose for patients with wild-type KRAS exon 2 metastatic colorectal cancer: a single-institution experience
por: Daoud, Mohamed A., et al.
Publicado: (2016)

KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer
por: Renaud, Stéphane, et al.
Publicado: (2016)

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer()
por: Matikas, Alexios, et al.
Publicado: (2017)

Comparative Analysis and Classification of Cassette Exons and Constitutive Exons
por: Cui, Ying, et al.
Publicado: (2017)

Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2–8) in Normal and Cancerous Breast and Prostate Cells
por: Hu, Dong Gui, et al.
Publicado: (2016)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2019)

SensiPath: computer-aided design of sensing-enabling metabolic pathways
por: Delépine, Baudoin, et al.
Publicado: (2016)

In vitro evaluation of Sensi-IP®: A soluble and mineralizing sensitivity solution
por: MacDonald, Kathleen, et al.
Publicado: (2021)

A qPCR technology for direct quantification of methylation in untreated DNA
por: Bendixen, Kamilla Kolding, et al.
Publicado: (2023)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
por: Greer, Kane L, et al.
Publicado: (2014)

High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment
por: Deng, Yanhong, et al.
Publicado: (2015)

Biased exon/intron distribution of cryptic and de novo 3′ splice sites
por: Královičová, Jana, et al.
Publicado: (2005)

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
por: Lemstrova, Radmila, et al.
Publicado: (2017)

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2020)

A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data
por: Mo, Fan, et al.
Publicado: (2008)

POEM, A 3-dimensional exon taxonomy and patterns in untranslated exons
por: Knapp, Keith, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_q59u71q73eh1c5nrb3v4qgfshm